(R)-1-(4-Fluorophenyl)but-3-en-1-amine hydrochloride
≥95%
- Product Code: 113461
CAS:
1391361-52-6
| Molecular Weight: | 201.67 g./mol | Molecular Formula: | C₁₀H₁₃ClFN |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD12068566 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, dry and sealed |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry as an intermediate in the synthesis of various pharmacologically active molecules. Its structure, featuring a fluorophenyl group and an amine moiety, makes it a valuable building block for the development of drugs targeting central nervous system disorders. Specifically, it is employed in the creation of compounds with potential antidepressant or anxiolytic properties. Additionally, the presence of the double bond in the butenyl chain allows for further chemical modifications, enabling the design of more complex molecules with enhanced biological activity. Its application is also seen in research focused on exploring new therapeutic agents for neurological and psychiatric conditions.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $296.02 |
+
-
|
| 0.250 | 10-20 days | $592.04 |
+
-
|
(R)-1-(4-Fluorophenyl)but-3-en-1-amine hydrochloride
This compound is primarily utilized in the field of medicinal chemistry as an intermediate in the synthesis of various pharmacologically active molecules. Its structure, featuring a fluorophenyl group and an amine moiety, makes it a valuable building block for the development of drugs targeting central nervous system disorders. Specifically, it is employed in the creation of compounds with potential antidepressant or anxiolytic properties. Additionally, the presence of the double bond in the butenyl chain allows for further chemical modifications, enabling the design of more complex molecules with enhanced biological activity. Its application is also seen in research focused on exploring new therapeutic agents for neurological and psychiatric conditions.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :